Protein Sciences Corporation (headquarters: Meriden, CT), manufacturer of Flublok® influenza vaccine, Sinergium Biotech (headquarters: Buenos Aires) and Mundo Sano, a private foundation with activities in Argentina, Spain and Africa said they will jointly develop a Zika virus vaccine to combat the recent outbreak of Zika that is wreaking havoc in Latin America and spreading to other continents.

The vaccine being developed is based on production of recombinant variations of the E protein from the Zika virus. Similar vaccine candidates produced at Protein Sciences against West Nile Virus and Japanese Encephalitis Virus, which are close relatives of the Zika virus, have previously been shown to neutralize their respective viruses in preclinical studies.